Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
417M
-
Number of holders
-
184
-
Total 13F shares, excl. options
-
438M
-
Shares change
-
-8.39M
-
Total reported value, excl. options
-
$7.6B
-
Value change
-
-$167M
-
Put/Call ratio
-
0.63
-
Number of buys
-
126
-
Number of sells
-
-86
-
Price
-
$17.34
Significant Holders of agilon health, inc. - Common Stock (AGL) as of Q2 2023
253 filings reported holding AGL - agilon health, inc. - Common Stock as of Q2 2023.
agilon health, inc. - Common Stock (AGL) has 184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 438M shares
.
Largest 10 shareholders include Clayton, Dubilier & Rice, LLC (100M shares), FMR LLC (60.8M shares), Capital World Investors (51.3M shares), MORGAN STANLEY (41.1M shares), WELLINGTON MANAGEMENT GROUP LLP (38.2M shares), VANGUARD GROUP INC (28.2M shares), Capital Research Global Investors (15.2M shares), T. Rowe Price Investment Management, Inc. (14.6M shares), BlackRock Inc. (12.9M shares), and Capital International Investors (9.41M shares).
This table shows the top 184 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.